TCGA: FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma - Rachel Liao
TCGA: Genomic Characterization of Squamous Cell Carcinoma of the Head Neck - David Hayes
TCGA: Comprehensive Analysis of Lung Adenocarcinoma - Matthew Meyerson
DDR2 Mutations in Squamous Cell Lung Cancer
What is FGFR, and Could It Be a Valuable Target for Patients with Lung Cancer?
TCGA: Network-Based Stratification of Tumor Mutations - Matan Hofree
Squamous Lung Cancer, Part 2: Genomic Testing
TCGA: Status Report and Insights From Leadership - Kenna Shaw
FGFR and Its Roll in Treating Squamous Cell Lung Cancer
TCGA: Adverse Outcomes in Clear Cell Renal Cell Carcinoma With Mutations - Ari Hakimi
TCGA: Comparative Mutational Analysis in Frozen and FFPE Tumor Samples - Gaddy Getz
GRACEcastUC088_Lung_Dr. Bonomi on Lung Cancer Targeted Therapies
GRACEcastUC-066_Lung_Dr. Lecia Sequist on Relevant Emerging Molecular Targets in Lung Cancer
EMCTO 2013: The sub-typing of lung cancer and squamous cell carcinoma
TCGA: Genomic Characterization of Cancer-Adjacent Tissue - Melissa Troester
TCGA: Status Reports and Insight from Leadership Q&A -- Matthew Meyerson and Ilya Shmulevich
GRACEcast-145_Lung_Highlights in Lung Cancer, 2013: Squamous Cell NSCLC and antiPD1
GRACEcastUC-040_Lung_Can We Bring The Advances in Targeted Therapy to Broader NSCLC Populations?
TCGA: Analysis of 3,000 Cancer Exomes to Identify Novel Cancer Drivers - Nickolay Khazanov
TCGA: Clear Cell Renal Cell Carcinoma Project - Chad Creighton
